Skip to main content

Advertisement

SpringerLink
Log in

Expression of VEGF, EGFR, and IL-6 in Gastric Adenomas and Adenocarcinomas by Endoscopic Submucosal Dissection

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The degree of intratumoral microvascular density is thought to affect tumor metastasis and prognosis in various human cancers, including gastric cancer. Despite recent medical advancements, gastric adenoma or adenocarcinoma remains a considerable therapeutic challenge. Endoscopic submucosal dissection (ESD) is a more recent approach that is now commonly used for radical resection of gastric adenoma and adenocarcinoma.

Aim and Methods

The expression of vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), and interleukin-6 (IL-6) are related to the prognosis of gastric adenocarcinoma. However, the expression of these factors in gastric adenoma/adenocarcinoma following ESD has not been clearly evaluated. Here, we report on our study of the expression of VEGF, EGFR, and IL-6 by immunohistochemical staining in extracted tissue from adenoma or adenocarcinoma of the stomach by ESD and subsequent evaluation of the correlation of VEGF, EGFR, and IL-6 with other clinicopathological parameters. The patient cohort consisted of 102 patients with adenoma or adenocarcinoma of the stomach.

Results

Immunohistochemical staining for VEGF and IL-6 was significantly higher in both high grade dysplasia and adenocarcinoma than in low grade dysplasia (P < 0.05). There was significant correlation between histological grade and intensity of immunohistochemical staining of VEGF (P = 0.039). Histological differentiation of adenocarcinoma was related to IL-6 expression (P = 0.028). The immunoreactivity of VEGF and IL-6 increased significantly in lesions >2 cm compared to lesions <2 cm (P < 0.05).

Conclusion

The immunohistochemical expression of IL-6 and VEGF can be considered to be useful for clinical diagnosis and follow-up of adenoma or adenocarcinoma of the stomach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4–6.

    Article  PubMed  CAS  Google Scholar 

  2. Tomoda M, Maehara Y, Kakeji Y, Ohno S, Ichiyoshi Y, Sugimachi K. Intratumoralneovascularization and growth pattern in early gastric carcinoma. Cancer. 1999;85:2340–2346.

    Article  PubMed  CAS  Google Scholar 

  3. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2 terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factors. Cancer Res. 1990;50:1774–1778.

    PubMed  CAS  Google Scholar 

  4. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–1478.

    Article  PubMed  CAS  Google Scholar 

  5. Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996;77:858–863.

    Article  PubMed  CAS  Google Scholar 

  6. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer. 1997;79:206–213.

    Article  PubMed  CAS  Google Scholar 

  7. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early release in primary breast cancer. Jpn J Cancer Res. 1994;85:1045–1049.

    PubMed  CAS  Google Scholar 

  8. Paley PJ, Staskus KA, Gebhard K, et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 1997;80:98–106.

    Article  PubMed  CAS  Google Scholar 

  9. Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res. 1997;3:861–865.

    PubMed  CAS  Google Scholar 

  10. Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999;5:1823–1829.

    PubMed  CAS  Google Scholar 

  11. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25.

    Article  PubMed  CAS  Google Scholar 

  12. Lang SA, Klein D, Moser C, et al. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther. 2007;6:1123–1132.

    Article  PubMed  CAS  Google Scholar 

  13. Galizia G, Lieto E, Orditura M, et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg. 2007;31:1458–1468.

    Article  PubMed  Google Scholar 

  14. Ito R, Nakayama H, Yoshida K, Matsumura S, Oda N, Yasui W. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma. Virchows Arch. 2004;444:324–331.

    Article  PubMed  CAS  Google Scholar 

  15. Huang SP, Wu MS, Wang HP, Yang CS, Kuo ML, Lin JT. Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. J Gastroenterol Hepatol. 2002;17:1165–1169.

    Article  PubMed  CAS  Google Scholar 

  16. Baselga J, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol. 2005;23:2445–2459.

    Article  PubMed  CAS  Google Scholar 

  17. Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol. 2003;21:2787–2799.

    Article  PubMed  CAS  Google Scholar 

  18. Srivastava A, Lauwers GY. Gastric epithelial dysplasia: the Western perspective. Dig Liver Dis. 2008;40:641–649.

    Article  PubMed  CAS  Google Scholar 

  19. Fondevila C, Metges JP, Fuster J, et al. p53 and VEGF expression are independent predictor of tumor recurrence and survival following curative resection of gastric cancer. Br J Cancer. 2004;90:206–215.

    Article  PubMed  CAS  Google Scholar 

  20. Ichikura T, Tomimatsu S, Ohkura E, Mochizuki H. Prognostic significance of the expression of vascular endothelial growth factor(VEGF) and VEGF-C in gastriccarcinoma. J Surg Oncol. 2001;78:132–137.

    Article  PubMed  CAS  Google Scholar 

  21. Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G. Vascular endothelial growth factor polymorphism in gastric cancer development prognosis, and survival. J Surg Oncol. 2006;94:624–630.

    Article  PubMed  CAS  Google Scholar 

  22. Obst B, Wagner S, Sewing KF, Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis. 2000;21:1111–1115.

    Article  PubMed  CAS  Google Scholar 

  23. Takehana T, Kunitomo K, Suzuki S, et al. Expression of epidermal growth factor receptor in gastric carcinomas. Clin Gastroenterol Hepatol. 2003;1:438–445.

    Article  PubMed  CAS  Google Scholar 

  24. Garcia I, Vizoso F, Martin A, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol. 2003;10:234–241.

    Article  PubMed  CAS  Google Scholar 

  25. Mammano E, Belluco C, Sciro M, et al. Epidermal growth factor receptor(EGFR): mutational and protein expression analysis in gastric cancer. Anticancer Res. 2006;26:3547–3550.

    PubMed  CAS  Google Scholar 

  26. Gamboa-Dominguez A, Dominguez-Fonseca C, Quintanilla-Martinez L, et al. Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system. Mod Pathol. 2004;17:579–587.

    Article  PubMed  CAS  Google Scholar 

  27. Hirono Y, Tsugawa K, Fushida S, et al. Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer. Oncology. 1995;52:182–188.

    Article  PubMed  CAS  Google Scholar 

  28. Sanz-Ortega J, Steingerg SM, Moro E. et al. Comparative study of tumor angiogenesis and immunohistochemistry for p53. c-ErbB2, c-myc and EGFR as prognostic factors in gastric cancer. Histopathology 2000;15:455–462.

    CAS  Google Scholar 

  29. McNamara D, El-Omar E. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig Liver Dis. 2008;40:504–509.

    Article  PubMed  CAS  Google Scholar 

  30. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1998;241:708–712.

    Article  Google Scholar 

  31. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990;11:443–449.

    Article  PubMed  CAS  Google Scholar 

  32. Bataille R, Jourdan M, Zhang XG, Klein B. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest. 1989;84:2008–2011.

    Article  PubMed  CAS  Google Scholar 

  33. Tsukamoto T, Kumamoto Y, Miyao N, Masumori N, Takahashi A, Yanase M. Interleukin-6 in renal cell carcinoma. J Urol. 1992;148:1778–1781.

    PubMed  CAS  Google Scholar 

  34. Seguchi T, Yokokawa K, Sugao H, Nakano E, Sonoda T, Okuyama A. Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J Urol. 1992;148:791–794.

    PubMed  CAS  Google Scholar 

  35. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol. 1991;164:1038–1042.

    PubMed  CAS  Google Scholar 

  36. Ravoet C, DeGreve J, Vandewoude K, et al. Tumor stimulating effects of recombinant human interleukin-6. Lancet. 1994;344:1576–1577.

    Article  PubMed  CAS  Google Scholar 

  37. Wu CW, Wang SR, Chao MF, et al. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol. 1996;91:1417–1422.

    PubMed  CAS  Google Scholar 

  38. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood. 1989;74:1360–1367.

    PubMed  CAS  Google Scholar 

  39. Hobisch A, Rogatisch H, Hittmair A, et al. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol. 2000;191:239–244.

    Article  PubMed  CAS  Google Scholar 

  40. Huang SP, Wu MS, Shum CT, et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci. 2004;11:517–527.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by research funds from Dong-A University.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Dong-A University College of Medicine, 3-ga 1, Dongdaesin-dong, Seo-gu, Busan, 602-713, Korea

    Shin-Ae Lee, Seok-Reyol Choi, Jin-Seok Jang, Jong-Hun Lee, Myung-Hwan Roh & Sang Ock Kim

  2. Department of Surgery, Dong-A University College of Medicine, Seo-gu, Busan, Korea

    Min-Chan Kim

  3. Department of Pathology, Dong-A University College of Medicine, Seo-gu, Busan, Korea

    Su-Jin Kim & Jin-Sook Jeong

Authors
  1. Shin-Ae Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seok-Reyol Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin-Seok Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jong-Hun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Myung-Hwan Roh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sang Ock Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Min-Chan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Su-Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jin-Sook Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seok-Reyol Choi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, SA., Choi, SR., Jang, JS. et al. Expression of VEGF, EGFR, and IL-6 in Gastric Adenomas and Adenocarcinomas by Endoscopic Submucosal Dissection. Dig Dis Sci 55, 1955–1963 (2010). https://doi.org/10.1007/s10620-009-0967-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0967-1

Keywords

Search

Navigation